U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT06858371) titled 'Testing the Effectiveness of AI Chatbots to Improve Public Knowledge and Attitudes Towards Depression' on Feb. 24.
Brief Summary: The purpose of this randomized controlled trial (RCT) is to find out whether using AI Chatbots can help the public better understand depression, reduce negative attitudes towards it, and encourage more people to seek help when needed. The study will also explore whether the Chatbot can help individuals feel more confident in supporting others who might be experiencing depression.
Participants will be randomly assigned to either:
1. AI-PsyTeacher Group: Participants interact with the AI psychology teache...